MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors

References

• Holland AJ, Cleveland DW. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 2009; 10:478-87; PMID:19546858; http://dx.doi.org/10.1038/nrm2718
   PubMed Web of Science ®Google Scholar
• Fung MK, Cheung HW, Wong H-L, Yuen H-F, Ling M-T, Chan K-W, Wong Y-C, Cheung AL, Wang X. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour. Biochim Biophys Acta 2007; 1773:821-32; PMID:17467818; http://dx.doi.org/10.1016/j.bbamcr.2007.03.014
   PubMed Web of Science ®Google Scholar
• Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Baxter JN, Parry JM. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Mutat Res 2004; 547:133-44; PMID:15013707; http://dx.doi.org/10.1016/j.mrfmmm.2003.12.009
   PubMed Web of Science ®Google Scholar
• Furlong F, Fitzpatrick P, O'Toole S, Phelan S, McGrogan B, Maguire A, O'Grady A, Gallagher M, Prencipe M, McGoldrick A, et al. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. J Pathol 2012; 226:746-55; PMID:22069160; http://dx.doi.org/10.1002/path.3035
   PubMed Web of Science ®Google Scholar
• Li G-Q, Li H, Zhang H-F. Mad2 and p53 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol 2003; 9:1972-5; PMID:12970887; http://dx.doi.org/10.3748/wjg.v9.i9.1972
   PubMed Web of Science ®Google Scholar
• Sumi T, Morishita M, Nakano Y, Teramae M, Fukuda T, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Ishiko O. Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer. Exp Ther Med 2012; 3:341-6; PMID:22969893; http://dx.doi.org/10.3892/etm.2011.407
   PubMed Web of Science ®Google Scholar
• Scintu M, Vitale R, Prencipe M, Gallo AP, Bonghi L, Valori VM, Maiello E, Rinaldi M, Signori E, Rabitti C, et al. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett 2007; 254:298-307; PMID:17498870; http://dx.doi.org/10.1016/j.canlet.2007.03.021
   PubMed Web of Science ®Google Scholar
• Tanaka K, Nishioka J, Kato K, Nakamura A, Mouri T, Miki C, Kusunoki M, Nobori T. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn J Cancer Res 2001; 92:952-8; PMID:11572763; http://dx.doi.org/10.1111/j.1349-7006.2001.tb01186.x
   PubMedGoogle Scholar
• Manchado E, Guillamot M, Malumbres M. Killing cells by targeting mitosis. Cell Death Differ 2012; 19: 369-77; PMID:22223105; http://dx.doi.org/10.1038/cdd.2011.197
   PubMed Web of Science ®Google Scholar
• Mikhailov A, Cole RW, Rieder CL. DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr Biol 2002; 12:1797-806; PMID:12419179; http://dx.doi.org/10.1016/S0960-9822(02)01226-5
   PubMed Web of Science ®Google Scholar
• Jackson JR, Patrick DR, Dar MM, Huang PS. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 2007; 7:107-17; PMID:17251917; http://dx.doi.org/10.1038/nrc2049
   PubMed Web of Science ®Google Scholar
• Kasai T, Iwanaga Y, Iha H, Jeang K-T. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J Biol Chem 2002; 277:5187-93; PMID:11729202; http://dx.doi.org/10.1074/jbc.M110295200
   PubMed Web of Science ®Google Scholar
• Tao W. The mitotic checkpoint in cancer therapy. Cell Cycle 2005; 4:1495-9; PMID:16258280; http://dx.doi.org/10.4161/cc.4.11.2130
   PubMed Web of Science ®Google Scholar
• Nitta M, Kobayashi O, Honda S, Hirota T, Kuninaka S, Marumoto T, Ushio Y, Saya H. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 2004; 23: 6548-58; PMID:15221012; http://dx.doi.org/10.1038/sj.onc.1207873
   PubMed Web of Science ®Google Scholar
• Cheung HW, Jin D-Y, Ling M-T, Wong Y-C, Wang Q, Tsao SW, Wang X. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res 2005; 65:1450-8; PMID:15735033; http://dx.doi.org/10.1158/0008-5472.CAN-04-0567
   PubMed Web of Science ®Google Scholar
• Fung MK, Cheung H-W, Ling M-T, Cheung AL, Wong Y-C, Wang X. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells. Br J Cancer 2006; 95:475-84; PMID:16880791; http://dx.doi.org/10.1038/sj.bjc.6603284
   PubMed Web of Science ®Google Scholar
• Fung MK, Han H-Y, Leung SC, Cheung HW, Cheung AL, Wong Y-C, Ling M-T, Wang X. MAD2 interacts with DNA repair proteins and negatively regulates DNA damage repair. J Mol Biol 2008; 381:24-34; PMID:18597777; http://dx.doi.org/10.1016/j.jmb.2008.05.080
   PubMed Web of Science ®Google Scholar
• Dotiwala F, Harrison JC, Jain S, Sugawara N, Haber JE. Mad2 prolongs DNA damage checkpoint arrest caused by a double-strand break via a centromere-dependent mechanism. Curr Biol 2010; 20:328-32; PMID:20096585; http://dx.doi.org/10.1016/j.cub.2009.12.033
   PubMed Web of Science ®Google Scholar
• Wang L, Yin F, Du Y, Chen B, Liang S, Zhang Y, Du W, Wu K, Ding J, Fan D. Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biol 2010; 31:225-32; PMID:20440596; http://dx.doi.org/10.1007/s13277-010-0036-6
   PubMed Web of Science ®Google Scholar
• Yin F, Du Y, Hu W, Qiao T, Ding J, Wu K, Liu Z, Fan D. Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells. Life Sci 2006; 78:1277-86; PMID:16214181; http://dx.doi.org/10.1016/j.lfs.2005.06.034
   PubMed Web of Science ®Google Scholar
• Li Y, Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996; 274:246-8; PMID:8824189; http://dx.doi.org/10.1126/science.274.5285.246
   PubMed Web of Science ®Google Scholar
• Gemma A, Hosoya Y, Seike M, Uematsu K, Kurimoto F, Hibino S, Yoshimura A, Shibuya M, Kudoh S, Emi M. Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers. Lung Cancer 2001; 32:289-95; PMID:11390010; http://dx.doi.org/10.1016/S0169-5002(00)00223-3
   PubMed Web of Science ®Google Scholar
• Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001; 409:355-59; PMID:11201745; http://dx.doi.org/10.1038/35053094
   PubMed Web of Science ®Google Scholar
• Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386:623-7; PMID:9121588; http://dx.doi.org/10.1038/386623a0
   PubMed Web of Science ®Google Scholar
• Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 2008; 180:665-72; PMID:18283116; http://dx.doi.org/10.1083/jcb.200712029
   PubMed Web of Science ®Google Scholar
• Luo X, Fang G, Coldiron M, Lin Y, Yu H, Kirschner MW, Wagner G. Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol 2000; 7: 224-9; PMID:10700282; http://dx.doi.org/10.1038/73338
   PubMedGoogle Scholar
• Sironi L, Mapelli M, Knapp S, De Antoni A, Jeang K-T, Musacchio A. Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a [safety belt] binding mechanism for the spindle checkpoint. EMBO J 2002; 21:2496-506; PMID:12006501; http://dx.doi.org/10.1093/emboj/21.10.2496
   PubMed Web of Science ®Google Scholar
• Yang M, Li B, Liu C-J, Tomchick DR, Machius M, Rizo J, Yu H, Luo X. Insights into mad2 regulation in the spindle checkpoint revealed by the crystal structure of the symmetric mad2 dimer. Plos Biol 2008; 6:e50PMID:18318601; http://dx.doi.org/10.1371/journal.pbio.0060050
   PubMedGoogle Scholar
• Yang M, Li B, Tomchick DR, Machius M, Rizo J, Yu H, Luo X. p31comet blocks Mad2 activation through structural mimicry. Cell 2007; 131:744-55; PMID:18022368; http://dx.doi.org/10.1016/j.cell.2007.08.048
   PubMed Web of Science ®Google Scholar
• Tipton AR, Wang K, Link L, Bellizzi JJ, Huang H, Yen T, Liu S-T. BUBR1 and closed MAD2 (C-MAD2) interact directly to assemble a functional mitotic checkpoint complex. J Biol Chem 2011; 286:21173-9; PMID:21525009; http://dx.doi.org/10.1074/jbc.M111.238543
   PubMed Web of Science ®Google Scholar
• Hara M, Özkan E, Sun H, Yu H, Luo X. Structure of an intermediate conformer of the spindle checkpoint protein Mad2. Proc Natl Acad Sci U S A 2015; 112:11252-7; PMID:26305957; http://dx.doi.org/10.1073/pnas.1512197112
   PubMed Web of Science ®Google Scholar
• Luo X, Tang Z, Rizo J, Yu H. The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20. Mol Cell 2002; 9:59-71; PMID:11804586; http://dx.doi.org/10.1016/S1097-2765(01)00435-X
   PubMed Web of Science ®Google Scholar
• Orth M, Mayer B, Rehm K, Rothweiler U, Heidmann D, Holak TA, Stemmann O. Shugoshin is a Mad1/Cdc20-like interactor of Mad2. EMBO J 2011; 30:2868-80; PMID:21666598; http://dx.doi.org/10.1038/emboj.2011.187
   PubMed Web of Science ®Google Scholar
• Ryan SD, Britigan EM, Zasadil LM, Witte K, Audhya A, Roopra A, Weaver BA. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proc Natl Acad Sci U S A 2012; 109:E2205-14; PMID:22778409; http://dx.doi.org/10.1073/pnas.1201911109
   PubMed Web of Science ®Google Scholar
• Wang L, Yin F, Du Y, Du W, Chen B, Zhang Y, Wu K, Ding J, Liu J, Fan D. MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer. Am J Clin Pathol 2009; 131:793-801; PMID:19461085; http://dx.doi.org/10.1309/AJCPBMHHD0HFCY8W
   PubMed Web of Science ®Google Scholar
• Burum-Auensen E, Skotheim RI, Schjølberg AR, Røislien J, Lothe RA, Clausen OP. Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors. J Carcinog 2010; 9:1; PMID:20411023; http://dx.doi.org/10.4103/1477-3163.60358
   PubMedGoogle Scholar
• Quimby BB, Arnaoutov A, Dasso M. Ran GTPase regulates Mad2 localization to the nuclear pore complex. Eukaryot Cell 2005; 4:274-80; PMID:15701789; http://dx.doi.org/10.1128/EC.4.2.274-280.2005
   PubMed Web of Science ®Google Scholar
• Lee SH, Sterling H, Burlingame A, McCormick F. Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle checkpoint. Genes Dev 2008; 22:2926-31; PMID:18981471; http://dx.doi.org/10.1101/gad.1677208
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bravo V, Maciejowski J, Corona J, Buch HK, Collin P, Kanemaki MT, Shah JV, Jallepalli PV. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell 2014; 156: 1017-31; PMID:24581499; http://dx.doi.org/10.1016/j.cell.2014.01.010
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15:1377-99; PMID:15319245; http://dx.doi.org/10.1093/annonc/mdh301
   PubMed Web of Science ®Google Scholar
• Mendoza J, Martínez J, Hernández C, Pérez-Montiel D, Castro C, Fabián-Morales E, Santibáñez M, González-Barrios R, Díaz-Chávez J, Andonegui MA, et al. Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours. Br J Cancer 2013; 109:68-75; PMID:23807173; http://dx.doi.org/10.1038/bjc.2013.303
   PubMed Web of Science ®Google Scholar
• Stoilov P, Daoud R, Nayler O, Stamm S. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum Mol Genet 2004; 13:509-24; PMID:14709600; http://dx.doi.org/10.1093/hmg/ddh051
   PubMed Web of Science ®Google Scholar
• Sureau A, Gattoni R, Dooghe Y, Stévenin J, Soret J. SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J 2001; 20:1785-96; PMID:11285241; http://dx.doi.org/10.1093/emboj/20.7.1785
   PubMed Web of Science ®Google Scholar
• Sze KM, Ching Y-P, Jin D-Y, Ng IO. Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer. Cancer Res 2008; 68:9194-201; PMID:19010891; http://dx.doi.org/10.1158/0008-5472.CAN-08-2600
   PubMed Web of Science ®Google Scholar
• Masuda A, Maeno K, Nakagawa T, Saito H, Takahashi T. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am J Pathol 2003; 163:1109-16; PMID:12937152; http://dx.doi.org/10.1016/S0002-9440(10)63470-0
   PubMed Web of Science ®Google Scholar
• Schweizer N, Ferrás C, Kern DM, Logarinho E, Cheeseman IM, Maiato H. Spindle assembly checkpoint robustness requires Tpr-mediated regulation of Mad1/Mad2 proteostasis. J Cell Biol 2013; 203:883-93; PMID:24344181; http://dx.doi.org/10.1083/jcb.201309076
   PubMed Web of Science ®Google Scholar
• Filippov V, Schmidt EL, Filippova M, Duerksen-Hughes PJ. Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes. Gene 2008; 420:34-41; PMID:18571879; http://dx.doi.org/10.1016/j.gene.2008.05.008
   PubMed Web of Science ®Google Scholar
• Mu R, Wang Y-B, Wu M, Yang Y, Song W, Li T, Zhang W-N, Tan B, Li A-L, Wang N, et al. Depletion of pre-mRNA splicing factor Cdc5L inhibits mitotic progression and triggers mitotic catastrophe. Cell Death Dis 2014; 5:e1151; PMID:24675469; http://dx.doi.org/10.1038/cddis.2014.117
   PubMed Web of Science ®Google Scholar
• Wassmann K, Liberal V, Benezra R. Mad2 phosphorylation regulates its association with Mad1 and the APC/C EMBO J 2003; 22:797-806; PMID:12574116; http://dx.doi.org/10.1093/emboj/cdg071
   PubMed Web of Science ®Google Scholar
• Voigt W. Sulforhodamine B assay and chemosensitivity. Methods Mol Med 2005; 110:39-48; PMID:15901925; http://dx.doi.org/10.1385/1-59259-869-2:039
   PubMedGoogle Scholar
• McNicholas S, Potterton E, Wilson KS, Noble ME. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr D Biol Crystallogr 2011; 67: 386-94; PMID:21460457; http://dx.doi.org/10.1107/S0907444911007281
   PubMed Web of Science ®Google Scholar
• The Uniprot Consortium. UniProt: a hub for protein information. Nucleic Acids Research 2015; 43(D1):D204–D212; http://dx.doi.org/10.1093/nar/gku989
   Google Scholar
• Li W, Cowley A, Uludag M, Gur T, McWilliam H, Squizzato S, Park YM, Buso N, Lopez R. The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic Acids Res 2015; 43:W580-4; PMID:25845596; http://dx.doi.org/10.1093/nar/gkv279
   PubMed Web of Science ®Google Scholar
• Zou KH, Hall WJ, Shapiro DE. Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests. Stat Med 1997; 16:2143-56; PMID:9330425; http://dx.doi.org/10.1002/(SICI)1097-0258(19971015)16:19%3c2143::AID-SIM655%3e3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16:73-81; PMID:15613948; http://dx.doi.org/10.1097/01.ede.0000147512.81966.ba
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) 2010; 7: 26; PMID:20374655; http://dx.doi.org/10.1186/1743-7075-7-26
   PubMed Web of Science ®Google Scholar